DBLVSDNA• 28 Days (Normalized)
DBL vs DNA (DoubleLine Opportunistic Credit Fund Common Shares of Beneficial Interest vs Ginkgo Bioworks Holdings Inc.)
Showing Closing Date Range from Sep 11 to Oct 9, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
DBL Performance $13.39
-4.7%
DoubleLine Opportunistic Credit Fund Common Shares of Beneficial Interest
Normalized Baseline0.00%
DNA Performance $13
+92.59%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
Alpha Spread Margin DNA LEADS
-97.29 pts
DNA outperforming by 97.29 percentage points
DBLDNA
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
DBL DNA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(21 dates)
| Date | DBL Price | DBL Gain (%) | DNA Price | DNA Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 09, 2026 | $13.39 | -4.70% | $13.00 | +92.59% | -97.29% |
| Oct 08, 2026 | $13.28 | -5.48% | $11.34 | +68.00% | -73.48% |
| Oct 07, 2026 | $13.27 | -5.55% | $11.47 | +69.93% | -75.48% |
| Oct 06, 2026 | $13.32 | -5.20% | $12.41 | +83.85% | -89.05% |
| Oct 05, 2026 | $13.17 | -6.26% | $14.98 | +121.93% | -128.19% |
| Oct 02, 2026 | $13.68 | -2.63% | $12.35 | +82.96% | -85.59% |
| Oct 01, 2026 | $13.56 | -3.49% | $12.50 | +85.19% | -88.68% |
| Sep 30, 2026 | $13.55 | -3.56% | $12.83 | +90.07% | -93.63% |
| Sep 29, 2026 | $13.55 | -3.56% | $11.96 | +77.19% | -80.75% |
| Sep 28, 2026 | $13.42 | -4.48% | $10.46 | +54.96% | -59.44% |
| Sep 25, 2026 | $13.56 | -3.49% | $10.66 | +57.93% | -61.42% |
| Sep 24, 2026 | $13.56 | -3.49% | $10.25 | +51.85% | -55.34% |
| Sep 23, 2026 | $13.65 | -2.85% | $8.58 | +27.11% | -29.96% |
| Sep 22, 2026 | $13.70 | -2.49% | $9.37 | +38.81% | -41.30% |
| Sep 21, 2026 | $13.74 | -2.21% | $7.98 | +18.22% | -20.43% |
Page 1 of 2